IRIS PubliCatt

La Regina, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 194
NA - Nord America 191
AS - Asia 101
AF - Africa 2
OC - Oceania 1
Totale 489
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 191
SE - Svezia 89
SG - Singapore 60
IT - Italia 48
CN - Cina 20
ID - Indonesia 19
IE - Irlanda 18
RU - Federazione Russa 9
DE - Germania 8
FI - Finlandia 6
FR - Francia 6
NL - Olanda 5
CZ - Repubblica Ceca 3
AT - Austria 2
EG - Egitto 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
IR - Iran 1
Totale 489
Salva come PNG Salva come JPEG
Città #
Chandler 61
Singapore 48
Jakarta 19
Dublin 18
Rome 16
Ashburn 13
San Mateo 11
Boston 9
Moscow 9
Princeton 9
Aprilia 6
Andover 4
Augusta 4
Helsinki 4
Los Angeles 4
Milan 4
Brno 3
Munich 3
Paris 3
Cairo 2
Cattolica 2
Hangzhou 2
Lappeenranta 2
New York 2
Washington 2
Wilmington 2
Albuquerque 1
Beijing 1
Dubai 1
East Brunswick 1
Groningen 1
Guangzhou 1
Houston 1
Kish 1
Mountain View 1
Nuremberg 1
Seattle 1
Vienna 1
Xi'an 1
Totale 275
Salva come PNG Salva come JPEG
Nome #
Small molecule inhibitors of kdm5 histone demethylases increase the radiosensitivity of breast cancer cells overexpressing JARID1B 53
Design, synthesis and biological evaluation of PDZ1 targeting NHERF1 inhibitors as anticancer agents 52
New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors 45
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 39
Drug design and synthesis of new indolylarylsulfones as HIV-1 non-nucleoside reverse transcriptase inhibitors 39
New indolylarylsulfone non-nucleoside reverse transcriptase inhibitors show low nanomolar inhibition of single and double HIV-1 mutant strains 36
Inhibition of dengue virus replication by novel inhibitors of RNA-dependent RNA polymerase and protease activities 34
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 33
Chiral Indolylarylsulfone Non-Nucleoside Reverse Transcriptase Inhibitors as New Potent and Broad Spectrum Anti-HIV-1 Agents 32
Indolylarylsulfones as novel potent anti-HIV-1 agents 28
Indolylarylsulfones as novel potent anti-HIV-1 agents 25
4-(3-Phenyl-4-(3,4,5-trimethoxybenzoyl)-1H-pyrrol-1-yl)benzenesulfonamide, a Novel Carbonic Anhydrase and Wnt/β-Catenin Signaling Pathway Dual-Targeting Inhibitor with Potent Activity against Multidrug Resistant Cancer Cells 19
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 14
RS6077 induces mitotic arrest and selectively activates cell death in human cancer cell lines and in a lymphoma tumor in vivo 13
Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment 11
Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor 11
Emerging Direct Targeting β-Catenin Agents 9
Targeting the Grb2 cSH3 domain: Design, synthesis and biological evaluation of the first series of modulators 7
Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy 6
Induction of Ferroptosis in Glioblastoma and Ovarian Cancers by a New Pyrrole Tubulin Assembly Inhibitor 6
Targeting CBP and p300: Emerging Anticancer Agents 5
Development of N-(4-(1H-Imidazol-1-yl)phenyl)-4-chlorobenzenesulfonamide, a Novel Potent Inhibitor of β-Catenin with Enhanced Antitumor Activity and Metabolic Stability 4
Totale 521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202284 0 0 0 0 0 0 0 41 3 1 24 15
2022/2023191 37 21 16 6 25 17 9 23 26 0 8 3
2023/2024127 3 26 3 5 5 10 1 2 13 5 33 21
2024/2025119 13 4 27 33 42 0 0 0 0 0 0 0
Totale 521